|
Investments in Unconsolidated Entities - Additional Information (Detail) (USD $)
|
12 Months Ended | 0 Months Ended | 0 Months Ended | 0 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Apr. 01, 2014
CyVek, Inc
|
Apr. 01, 2014
CyVek, Inc
|
Apr. 01, 2014
CyVek, Inc
Scenario one
|
Apr. 01, 2014
CyVek, Inc
Scenario Two
|
Apr. 01, 2014
CyVek, Inc
Scenario Two
|
Apr. 01, 2014
CyVek, Inc
Scenario Three
|
Apr. 01, 2014
CyVek, Inc
Scenario Three
|
|
| Investments in and Advances to Affiliates [Line Items] | ||||||||||
| Investment in common stock | $ 10,000,000 | $ 0 | $ 0 | $ 10,000,000 | ||||||
| Cost method investment ownership percentage in common stock | 19.90% | |||||||||
| Period to achieve certain commercial milestones from the date of Agreement | 12 months | |||||||||
| Payments to acquire business | 60,000,000 | |||||||||
| Business combination contingent consideration | 35,000,000 | |||||||||
| Contingent payment period | 30 months | |||||||||
| Cash payment percentage of excess of revenue | 50.00% | |||||||||
| Net sales | $ 357,763,000 | $ 310,575,000 | $ 314,560,000 | $ 100,000,000 | ||||||
| Business combination contingent consideration arrangements description | If, within twelve months of the date of the Agreement, CyVek meets commercial milestones related to the sale of its products, the Company will acquire CyVek through a merger, with CyVek surviving as a wholly-owned subsidiary of the Company. If the merger is consummated, the Company will make an initial payment of $60.0 million to the other stockholders of CyVek. The purchase price payable at the closing of the merger may be adjusted based on the final levels of cash, indebtedness and transaction expenses of CyVek as of the closing. The Company will also pay CyVek’s other stockholders up to $35.0 million based on the revenue generated by CyVek’s products and related products before the date that is 30 months from the closing of the Merger. The Company will also pay CyVek’s other stockholders 50% of the amount, if any, by which the revenue from CyVek’s products and related products exceeds $100.0 million in calendar year 2020. | |||||||||